Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

CSS Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance


BUFFALO, N.Y., Jan. 25, 2022 /PRNewswire/ -- CSS Health, a leading provider of Medication Therapy Management Software and Services, today announced it's Payer Services unit (formerly CSS) has earned Certified status for information security by HITRUST.

CSS Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST CSF Certified status demonstrates that the organization's CSS Health has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places CSS Health in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

"Technology-enabled Pharmacy Services companies, like ours, are under more pressure than ever to meet complex compliance and privacy requirements that include technical and process elements such as NIST, ISO, and COBIT," said James A. Clair , CEO  at CSS Health. "We are pleased to demonstrate to our customers the highest standards for protecting sensitive data and information by achieving HITRUST CSF Certification."

"In today's ever-changing threat landscape, HITRUST is continually innovating to find new and creative approaches to address challenges," said Jeremy Huval, Chief Innovation Officer, HITRUST. "CSS Health's HITRUST CSF Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance."

About  CSS Health
CSS Health provides a comprehensive Medication Therapy Management (MTM), adherence and compliance drug packaging solution for health plans, pharmacy benefit managers (PBMs), pharmacies, facilities, and patients. Our dedicated leadership team has deep and broad experience in payer and pharmacy services. CSS Health brings together Clinical Support Services, a leader in MTM clinical software and services, and Medicine-On-Time, an innovator in multi-dose and single dose compliance packaging and prescription management software for more than 30 years, in an end-to-end medication management solution. For more information about CSS Health, please visit www.csshealth.com

CSS Health Media Contact:                                                   
Miklos Van Halen, CTO
CSS Health
[email protected]              

                               

SOURCE CSS Health


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: